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Abstract
Background: Measles virus (MV) causes T cell suppression by interference with phosphatidylinositol-3-kinase (PI3K)
activation. We previously found that this interference affected the activity of splice regulatory proteins and a T cell inhibitory
protein isoform was produced from an alternatively spliced pre-mRNA.
Hypothesis: Differentially regulated and alternatively splice variant transcripts accumulating in response to PI3K abrogation
in T cells potentially encode proteins involved in T cell silencing.
Methods: To test this hypothesis at the cellular level, we performed a Human Exon 1.0 ST Array on RNAs isolated from T
cells stimulated only or stimulated after PI3K inhibition. We developed a simple algorithm based on a splicing index to
detect genes that undergo alternative splicing (AS) or are differentially regulated (RG) upon T cell suppression.
Results: Applying our algorithm to the data, 9% of the genes were assigned as AS, while only 3% were attributed to RG.
Though there are overlaps, AS and RG genes differed with regard to functional regulation, and were found to be enriched in
different functional groups. AS genes targeted extracellular matrix (ECM)-receptor interaction and focal adhesion pathways,
while RG genes were mainly enriched in cytokine-receptor interaction and Jak-STAT. When combined, AS/RG dependent
alterations targeted pathways essential for T cell receptor signaling, cytoskeletal dynamics and cell cycle entry.
Conclusions: PI3K abrogation interferes with key T cell activation processes through both differential expression and
alternative splicing, which together actively contribute to T cell suppression.
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Introduction
Suppression of T cell activation and function ranks amongst the
most powerful strategies of viruses to modulate host responses. In
particular, viruses establishing persistent infections in their hosts
exploit numerous strategies to prevent activation of virus-specific
helper or effector T cells by interfering with processing and/or
presentation of viral peptides on MHCI or II molecules, and thus
evade immune recognition (for a recent review see [1–4]). Much
less frequently, viruses may also cause a generalized, non-specific
suppression of T cell activation, and in humans, both HIV and
measles virus (MV) are paradigms of this scenario. In HIV
infection, immunosuppression is maintained and progressive,
while that induced by MV is transient, yet also almost exclusively
accounts for the continuously high rates of morbidity and
mortality associated with the acute disease [5–7]. MV immuno-
suppression is typically associated with an expansion block of
polyclonally or antigen-specific stimulated peripheral blood T
cells, the vast majority of which are uninfected, indicating that
they were actively silenced [7]. Soluble mediators accounting for
MV T cell silencing have not been detectable, yet both in vitro and
animal experimentation suggests that MV proteins can act as
effectors interfering with T cell activation [8–10].
The highly efficient, generalized inhibition of T cells by MV
suggests that pathways centrally involved in relaying T cell
receptor (TCR) signaling to promote cell cycle progression would
be targeted independently of direct infection of T cells. Indeed, the
MV glycoprotein complex interacts with an unknown receptor to
abrogate S phase entry of primary T cells in vitro and in vivo
[11,12]. On a molecular level, TCR driven activation of the
phosphatidylinositol-3(PI3)/Akt kinase pathway, which is key to T
cell activation and expansion, was identified as a prime target of
MV mediated inhibition, and consequently, overexpression of a
constitutively active Akt protein alleviated MV T cell paralysis to a
major extent [13]. Lack of Cbl-b degradation and activation of
sphingomyelinases are apparently upstream of MV surface
interaction mediated PI3K interference [14,15], yet specific
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molecular targets supporting this particular mode of T cell
silencing remained largely undefined. They may include regula-
tion of activity and/or subcellular redistribution of known PI3K
downstream targets such as the Vav, GSK-3b, and FOXO1, the
importance of which in T cell S phase entry is established [16,17].
In line with earlier observations [18–20], we confirmed that
certain splicing accessory factors are subject to PI3K interference,
induced either by MV or on pharmacologic PI3K inhibition by
LY294002 or wortmannin in T cells. Importantly, PI3K
interference by either means gave rise to production of a SHIP145
5-phosphatidylinositol-phosphatase isoform, SIP110, which was
produced from intron-retaining SHIP145mRNA, in T cells. When
ectopically expressed from cloned cDNA, SIP110 interfered with
TCR-driven expansion and thus acted as a T cell silencer [21].
This finding suggested that PI3K targets altered at the level of
alternative splicing on inhibition of the enzyme might have this
activity and SIP110 identified by chance on MV interruption of
this pathway might represent an example of others yet to be
identified.
Differentially regulating the output of up to 94% of human gene
transcripts, alternative splicing (AS) generates diversity in the
human proteome by inclusion or exclusion of exonic/intronic
sequences and thereby mRNA stability and the composition of
functionally organized protein domains (for review see [22,23]).
While AS has been recognized in T cell differentiation and
activation, little is known of its functional importance [24–27].
The number of genome-wide analyses of AS in these cells is
limited, and alterations thereof in response to immunosuppressive
conditions have not yet been reported. Because of its key role in
controlling cell cycle entry and cell survival, transcripts accumu-
lating in response to PI3K inhibition in activated T cells may serve
as T cell quiescence biomarkers or have the potential to act as T
cell silencers. Because both transcription and splice accessory
factors are PI3K effectors [16,18–20,28,29], alterations in the T
cell transcriptome on inhibition of the enzyme would be expected
to occur at the level of overall gene regulation, yet also alternative
splicing (AS), as already evidenced for SHIP145. To investigate
early alternative splicing (AS) and differential gene expression in
response to PI3K interference in T cells at a general level, we
performed GeneChip Exon array analysis on RNAs isolated from
human T cells pre-exposed to LY294002, or not, prior to a 24 h
phorbolester/ionomycin exposure. Based on existing algorithms
for the detection of alternative splicing events we developed a
simple method to identify exons that are enriched under
treatment. Transcripts detected specifically in PI3K inhibited cells
were assigned to categories defining either differentially regulated
(RG) (619 candidates) and alternatively spliced (AS) species (2192
candidates). These gene lists were analyzed for functional
annotation and representation in molecular networks and
pathways, and selected transcripts from these lists were validated
by RT-PCR and qPCR.
Methods
Lymphocyte isolation, stimulation, RNA extraction and
quality control
Human peripheral blood mononuclear cells obtained from
healthy donors served as the source for T cells. These were
enriched on nylon wool columns (purity of CD3+ cells: on average
85%). Individual samples maintained in RPMI1640/10% FCS
were halved: one half was stimulated for 24 h with 40 ng/ml PMA
(Calbiochem) and 0.5 mM ionomycin (Sigma) (stimulated only, S),
the other half was stimulated after a 2 h exposure to 50 mM
LY200492 (Calbiochem) For the inhibited/stimulated samples, the
abbreviation I is used to avoid confusion with SI (splicing index)
and IS (immunological synapse). Total RNA was extracted using
an RNeasy Mini Kit (QIAGEN). The integrity of the RNAs was
controlled by gel analysis followed by determining RNA integrity
numbers (RIN) using a Bioanalyzer (Agilent, Santa Clara, CA) for
those RNAs that were utilized for the Exon array (RIN 8.6 to 9.7
were used).
The use of the human material was approved by the ethics
committee of the University of Wuerzburg. Because only cells are
used and are without identifiers, this work is exempt from
institutional review board review.
GeneChipH Human Exon 1.0 ST array profiling
cDNA and cRNA synthesis of 100 ng of total RNA of both S
and I cells was processed according to the manufacturer’s
(Affymetrix, Santa Clara, CA) instructions and hybridized on
GeneChip Human Exon 1.0 ST Arrays (Affymetrix). Hybridiza-
tion, washing and scanning were carried out according to
manufacturer’s (Affymetrix) instructions. Data are deposited in
GEO, with accession number GSE38255.
Selection of candidate genes
Probe set signal intensities were summarized using the
Expression Console software (Affymetrix). The probe set summa-
rization algorithm PLIER was used for the exon level and
iterPLIER for gene level analysis. In both cases only probe sets
annotated as ‘‘core’’ were included. For all further analysis the
statistical language R, including different packages from the
Bioconductor project (www.bioconductor.org), was used. For
quality control, scale factor, provided by the Affymetrix system,
degradation plot and correspondence analysis were evaluated.
Exon level data and gene level data were normalized by quantile-
quantile normalization [30].
Prefiltering. Low intensity gene/exons, defined as having an
average signal intensity of both groups below the 10%-quantile of
the average total intensities of all samples, were excluded to correct
for ‘‘unexpressed’’ genes and poorly performing genes/exons.
Genes/exons exhibiting strong individual variations (within group
variance .1) and thus having poor reproducibility were excluded.
For the detection of splice variants, only exons having a
corresponding gene value were included. Next, the average
log2(ratios) between I and S were calculated at the probeset level
as well the gene level and a splicing index (SI) was calculated for
each probeset as the difference between probeset ratio and the
corresponding gene ratio [31].
Alternatively spliced (AS) candidate genes: Assuming that
alternative splicing correlates with the extent of SI divergence,
the range of all SIs of a corresponding gene was calculated and a
range (max SI – min SI) cutoff of 1 was applied to each gene. In
previous experiments we observed a slightly higher variation of
signal intensities in Affymetrix exon arrays compared to 39IVT
arrays. This may be because the selection of optimal probesets is
more difficult due to closer spacing [32]. To avoid false positive AS
genes due to possible outliers, we applied a sliding window
approach with a window size of 3 to emphasize longer stretches of
equally regulated probesets and to down-weigh single peaks. This
sliding window was applied to the selected genes comprising more
than 6 probesets (26 window size), followed by a subsequent
second filtering using a range-cutoff of 0.75. To test for
dependencies between changes in transcription rate and exon
inclusion as described [32] in several microarray samples, we
plotted SI against logFC, but detected no visible bias (data not
shown).
Alternative Splicing in T Cell Suppression
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Regulated candidate genes (RG). All expressed genes were
used, regardless of a corresponding transcript ID within the exon
list. In a first approach, for the calculation of the log fold change
and p-value we used the Limma (Linear Models for Microarray
Analysis) package [33] to compute a modified t-test, based on the
normalized core gene level data. A gene was defined as
differentially regulated, if the fold change was above 1.5 and p-
value,0.01. However, taking the average intensity of all exons
was susceptible to false positives in the case of genes being strongly
spliced. For example, TRIM47 showed a gene log fold change of
21.67 and an adjusted p-value of 0.0004. However, only exons 5
and 6 display a significantly lower expression in the inhibited
samples (Figure 1). Therefore, in a second approach, we calculated
the modified t-test on the normalized core exon level data. An
exon was defined as differentially expressed, if the fold change was
above 1.35 with an overall fold change for a gene .1.35. We
decided to lower the required fold change compared to gene wise
calculation, because of the higher number of observations. In
addition and in accordance with the definition of a gene being
spliced, at least 90% of all exons were required to be differentially
expressed. Finally, spliced genes were excluded from the list.
Functional analysis of gene lists
Functional analysis was performed using web-based tools,
including DAVID (http://david.abcc.ncifcrf.gov/tools.jsp), for
functional clustering, the Gene Set Analysis Toolkit V2 (http://
bioinfo.vanderbilt.edu/webgestalt), for GO term enrichment
analysis, and KEGG Mapper (http://www.genome.jp/kegg/
tool/color_pathway.html) for pathway mapping using the default
settings. Additional functional clusters and text mining for gene
interactions were generated through the use of IPA (Ingenuity
Systems, www.ingenuity.com).
Identification of T cell suppression genes from public
databases
Previously predicted T cell suppression genes were extracted
from public databases by extracting microarray datasets from
GEO (http://www.ncbi.nlm.nih.gov/geo/) and ArrayExpress
(www.ebi.ac.uk/arrayexpress), transcript data from dbEST
(www.ncbi.nlm.nih.gov/dbEST), and alternative splicing data
and information from Ensembl (www.ensembl.org), Genecards
(www.genecards.org) and Entrez (http://www.ncbi.nlm.nih.gov/
Entrez). Gene lists were generated to identify genes overexpressed
during T cell suppression, as well as those showing alternative
transcripts under normal versus T cell suppression conditions
(Table S1). These lists were compared to those obtained from the
exon array data.
Class validation by semiquantitative RT-PCR and qPCR
For RT-PCR, cDNA was synthesized from 2 mg total RNA (S
or I) by oligo-d(T) primed reverse transcription using the First
Figure 1. Selected AS (TRIM47, WRAP53, CHN1; left) and RG (DTL, SLFN5; right) gene views showing probe set intensity plots (graphs)
for each stimulated only (S, blue) or stimulated/inhibited (I, red) samples. Exons assigned with probe sets, location of primers within
constant and AS regions and expected fragment lengths on RT-PCR analyses (which are exemplified each right to the corresponding graphs; one out
of at least three independent experiments is shown) are indicated below the transcript profiles (A). Samples prepared as in A. were used for qPCR
analyses with amplification levels for S (white bars) and I (black bars) being indicated. Data shown were obtained using a selected pair of RNAs (S and
I), assays were performed in triplicate (B).
doi:10.1371/journal.pone.0050695.g001
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Strand cDNA Synthesis Kit (Fermentas). Illustra PuReTaq Ready-
To-Go PCR beads (0.5 ml tubes, GE healthcare) were used to
amplify DTL, SLFN5, TRIM47, WRAP53 and CHN1 transcripts
(denaturing at 94uC for 30 s, annealing at 58uC for 1 min and
elongation at 72uC for 2 min, 25–35 cycles). For the RG DTL and
SLFN5, two primer pairs were used spanning two arbitrarily
chosen exon boundaries and for the AS TRIM47, WRAP53 and
CHN1, one primer pair spanning exon boundaries within the
predicted AS region and one primer pair within the constant
region were used (see Table S2 for primer sequences, locations and
expected fragment lengths). b-actin served as the control for the
RT-PCRs (FW 514 bp 59 GCACTCTTCCACCTTCCTTCC,
REV 514 bp 59 TCACCTTCACCGTTCCAGTTTT). Primers
used in CD44 exon specific PCRs were as follows: v3 (variable
exon 3, also equating to exon 8 (out of 20)),: 59- CAGGCTGG-
GAGCCAAATGAAGA-39 and 59-TGTTCA-CCAAATGCAC-
CATTTCC-39 (constant exon 19 (c19) specific); c5, 59-TTTA-
CACCTTTTCTACTGTACACC-39 and exon c19 specific
reverse primer. The PCR products were separated on a 2.5%
agarose gel containing GelRed (1:30000, Genaxxon) for visuali-
zation. When indicated, AIDA software was used to quantify
signal intensities to allow for semi-quantitative analyses by
normalizing transcript specific signals to those of actin, and
subsequently, to compare S and I samples.
For qPCR the ColorFlash SYBRH Green qPCR Kit (F-416,
Finnzymes) was used to prepare mastermixes, each containing 16
SYBR Green Mastermix, each 500 nM forward and reverse
primer (same primers as for RT-PCR), 12.5 nM Fluorescein
Calibration Dye (BioRad) and DEPC-H2O up to 19 ml (final
volume). 1 ml cDNA (S or I) was applied in triplicate to wells of a
96-well plate as was a no template control (H2O). Following
addition of 19 ml mastermix to each PCR template, the following
iCycleriQH experimental protocol was used: denaturation (95uC
for 7 min), amplification and quantification repeated 45 times
(95uC for 10 s, 60uC for 30 s), melting curve (52¨C 95uC with a
heating increase of 0.5uC every 10 s) and a final cooling step to
15uC. For a control and quantification, the Quantitect Primers
UBC (ubiquitin C) and YWHAZ (tyrosine-3-monooxygenase/
tryptophan5-monooxygenase activation protein, zeta polypeptide)
were used (Qiagen).
The DDCT-value was determined by the iCycler program and
used for comparative quantification by the DDCT- method. This
method is suitable for a quick estimation of the relative expression
ratio between two groups (S or I), but assumes optimal and
identical amplification efficiencies of target and reference genes.
The use of two housekeeping genes, which allowed for exact
quantification, required normalization with the geometric mean.
An overview of cell treatment, hybridization and data analysis
steps is given in Figure 2.
Results
Identification and categorization of RG and AS gene
products as a function of PI3K inhibition in activated T
cells
Our work piloting this study revealed that MV interaction with
an as yet unknown surface receptor abrogates activation of the
PI3K by TCR signaling, and as a consequence of this, alters the
activity of splice regulatory factors and production of a fully spliced
mRNA for SHIP145 in T cells [21]. To assess alterations of
genome-wide early transcription upon suppression of PI3K
signaling in activated T cells, we decided to use a robust
stimulation protocol (phorbolester/ionomycin, P/I) which fully
reproduces TCR-mediated activation performed by CD3/CD28
crossligation in the pilot study. We also decided to replace MV by
a commercial inhibitor (LY294002, targeting the ATP-binding site
of the PI3K) for abrogating PI3K activation (added 2 h earlier) to
avoid virus preparation related variances (such as purity and
concentration), but also to cope with potential differences in
expression levels and membrane density of the unknown receptor
used by MV for PI3K interference. To record efficient P/I
activation of T cells, CD44 exon V3 exclusion known to occur on
T cell stimulation was followed at various time intervals by RT-
PCR (Figure S1). Thus, for array analysis, T cells enriched from
PBMCs of 7 independent healthy donors were each halved with
only one aliquot being exposed to LY prior to P/I stimulation to
obtain stimulated (S) and stimulated/inhibited (I) samples. RNAs
were isolated from paired samples after 24 h, and, following
quality control by RIN level determination, 2 paired samples were
discarded, and the five remaining pairs (S and I per donor) were
used for analysis with Affymetrix Human Exon 1.0 ST arrays,
which contain multiple probe sets interrogating all currently
known exon sequences in the human genome.
Extraction of candidate genes and class assignment
Using core probe sets only and discarding exons as well as
transcripts unexpressed in both groups, 283,927 probe sets
corresponding to transcript cluster IDs remained for filtering after
matching probe set and transcript IDs. Filtering for low expressed
probe sets also removed effects such as non-responsive probe sets
that might result in an increased number of false positive, as
described in [34]. One sample was identified as an outlier by
quality control plots, thus, the pair was not recruited into the
analysis. To select alternatively spliced genes, in a first step, a splice
index (SI) [31] for each probe set was calculated as the log ratio
(logFC) of the probe set intensities and gene intensities. Based on
the idea that the likelihood of alternative splicing of a gene
correlates with variation levels of the SIs of its probe sets, the SI
range for each gene was determined. Applying the filters described
in the methods section, 6156 transcripts were categorized as being
AS. To further increase stringency and to emphasize consecutive
probe sets being regulated in the same direction, a sliding window
was applied to each transcript represented by more probe sets than
twice the window size (window size = 3). After a second filter step
2192 genes were finally assigned as AS (Table S3). Calculating a
modified t-test using the Bioconductor package Limma for the
selection of differential exon signals and selecting regulated genes
(RG) resulted in a total of 619 genes, 280 of which were up-
regulated and 373 were down-regulated (Table S4).
Validation of class assignment
Based on the distribution of log signal intensities and splice
indices of the probesets, 9 candidate genes were chosen from the
RG and 7 from the AS class list for RT-PCR analyses (Table 1).
To validate assignment to the RG class, primers were randomly
chosen for two independent regions (exemplified in Figure 1A,
right graphs, denticeless homolog (DTL) [35] and Schlafen5
(SLFN5) [36]), while for the AS class, primers were designed within
the AS and the constant region (for examples see Figure 1A, left
graphs, tripartite motif containing 47 (TRIM47) [37], WD repeat
domain 79 (WRAP53) [38], and chimerin 1 (CHN1) [39]). Two-
step RT-PCRs were performed using cDNAs prepared from
paired RNA samples used to probe the Exon arrays, and
additional pairs prepared according to the same stimulation/
inhibition protocol. RT-PCR based validation always confirmed
assignment of RGs to this class. Thus, when normalized to the
respective actin-specific amplificate, both amplificates of the RG
analyzed were down- or up-regulated upon LY294002 treatment
Alternative Splicing in T Cell Suppression
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as exemplified for DTL (about 45% down) and SLFN5 (about
130% up) (Figure 1A, right panels). These semi-quantitative
analyses were quantitatively confirmed by qPCR (Figure 1B).
Similarly, validation of predicted and visually inspected AS
transcripts both by RT-PCR (Figure 1A, left panels) and qPCR
(Figure 1B) confirmed differences in the accumulation levels of
transcript amplified from within the AS region (49% for TRIM47,
83% for WRAP53 and 85,2% for CHN1). For regions predicted
not to be subjected to alternative splicing, results were quite
unambiguous because in most cases, differences with regard to
accumulation levels were seen (not shown). However, because
relative accumulation levels between the AS and the constant
region were unrelated (in contrast to RG transcripts), assignment
of the transcripts to the AS class appeared valid.
Functional analysis
For pathway assignment using DAVID, pathways showing a p-
value,0.01 and containing a minimum number of genes for the
corresponding term of 2, were considered to be significantly
enriched. Pathway analysis revealed that AS genes appeared to be
preferentially associated with extra cellular matrix (ECM)-receptor
interaction and focal adhesion, purine metabolism, and natural
killer cell mediated cytotoxicity, while RGs were major targets in
cytokine-receptor interaction, the Jak-STAT pathway and DNA
replication (Figure 3). Combining both AS and RG genes,
functions involved in signaling, cell cycle, and DNA replication,
recombination and repair were mainly affected. In concordance
with functional clustering using DAVID, text mining resulted in
networks including cell cycle with the highest scores, which is in
line with the established importance of PI3K signaling in cell cycle
progression in T cells [40][41][42].
The Gene Ontology (GO) analysis identified RG genes as being
enriched in immune response and DNA replication, whereas AS
genes were preferentially related to cell migration and motility
processes. Cell cycle regulation was enriched in both classes of
genes in the GO analysis. At the level of subcellular distribution,
AS tended to be enriched at the plasma membrane (encoding
receptors and ECM interaction), while RGs, irrespective of
whether they were up- or down-regulated, were more commonly
found in association with intracellular organelles and related
biochemical processes (Figure S2, S3 and S4). When analyzed
separately by GO analysis, down-regulated RGs were significantly
overrepresented in pathways regulating immune response, cyto-
kine activity, DNA replication and response to DNA damage,
while up-regulated RGs were overrepresented in DNA assembly
and packaging, and receptor and protein kinase activity (MAP3K3,
TNK, CLK1, TESK2, SGK3, CDKL5, NUAK2). KEGG pathways
over-represented in the up-regulated set include SNARE interac-
tions in vesicular transport (hsa04130) and the p53 signaling
pathway (hsa04115), while those in the down-regulated set include
cytokine–cytokine receptor interaction (hsa04060), DNA replica-
tion (hsa03030), and the Jak–STAT signaling pathway (hsa04630).
Figure 2. Overview of cell treatment, hybridization and prefiltering of the resulting data sets (A), selection of alternatively spliced genes (B) and
selection of differentially expressed genes (C).
doi:10.1371/journal.pone.0050695.g002
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On specific interrogation of the combined AS and RG lists, 15
members of TNF/TNF-R family were found targeted on PI3K
ablation (Table 2), and interestingly, only three of them (FAIM3,
TNFSF8 and TNFRSF10D) were down-regulated while all others
were AS.
Overlaps between the gene lists and previously published data
on genes responsive to PI3K activity alterations resulting from the
text search tool within IPA include for the AS list: CYBB, MAPK3,
NOS3 and TERT and for the RG genes: CDKN1A (p21WAF),
which, in line with its CDK inhibitory activity, is strongly up-
regulated. Because PI3K activity abrogates that of FOXO1,
FOXO1 targets such as SESN3, CDKN1A, SAT1, and VCL were
found up-regulated [43][44],[45] while other typical FOXO1
targets, such as FASL and P27KIP were not detectably affected.
Corroborating the role of PI3K in cell cycle progression, bcl-
family members (BCL-11B, BCL-2, BCL-3, and BCL-9L) and
transcripts coding for cyclin-dependent kinase inhibitors
(p16INK4a and p18INK4b) were found altered, yet interestingly,
at the level of differential exon inclusion.
RG and AS gene representation in public data on T cell
suppression
Because they are detected by the array, genes identified by the
assay as a whole after filtering conditions should be expressed in
the RNA samples analysed. These were lymphocytes enriched for
T cells (on average 85% CD3+ cells), yet also contained
contaminating B and NK cells. We thus aimed to relate findings
from our analyses to genes known to specifically be associated with
key T cell functions and viability. For this, we first determined the
overlap of our gene lists with those containing gene functions
important in chemokine signaling (hsa4062), leukocyte transen-
dothelial migration (hsa04670) and TCR signaling (hsa04660),
which yielded an overlap of 18 genes for RG and 24 genes for AS
(Table S5).
Of those, several are directly implicated in perception and relay
of TCR signaling (Figure 4). Both CD3G (encoding the c
component of the CD3 TCR complex) and CD4 were found to
be down regulated, while LCK, an essential kinase in propagating
TCR signaling, was targeted at the level of AS. Interestingly, LCK
transcript variants initiated at alternative transcription start sites
Table 1. RG and AS class transcripts RT-PCR amplified for validation of class assignment performed on a representative number of
independent RNAs for RGs.
class gene symbol alternative name gene function class confirmed
RG
SLFN5 Schlafen 5 unknown yes
DTL denticeless E3 protein ligase homologue yes
PFKM PFK1 phosphofructokinase yes
DOK2 p56DOK2 RasGAP adapter yes
ARHGEF6 COOL2 Rac/Cdc42 guanosine exchange factor yes
RAD51AP1 PIR51 RAD associated protein 1 yes
HELLS LSH lympoid specific helicase yes
DNMBP TUBA dynamin binding protein yes
SESN3 Sestrin 3 regulator of TORC activity yes
AS
TRIM47 Tripartite motif-containing
protein 47
unknown V: 10/10
C: 9/10
WRAP53 WD repeat containing,
antisense to p53
p53 regulator, telomerase complex V: 5/7
C: 1/7
CHN1 Chimerin 1 RhoGTPase activator V: 5/5
C: 2/5
TPRG p63 regulated gene 1 protein unknown V: 4/6
C: 2/6
STAP2 Substrate of breast cancer
kinase
adaptor V: 7/7
C: 3/7
IL4I1 Fig1, IL-4 induced protein 1 L-phenyl-oxidase, inhibition of T cell proliferation V: 4/6
C: 2/6
FBX06 F box protein 6 Subunit of the SKP1/cullin-F-box complex,
ubiquitination
V: 5/8
C: 5/8
The frequencies of AS transcript analyses per variable (v) or constant (c) regions are indicated, and those matching AS criteria (differing in the AS region and regulated
differently than the AS region within the C region) are indicated. Bold gene symbols mark genes for which, based on Gene annotation, as yet no alternatively spliced
transcripts were described.
doi:10.1371/journal.pone.0050695.t001
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are described, yet so far, alternative splicing has not been linked to
variants at the protein level. A group of affected genes relevant to
TCR signaling includes the AS guanosine exchange factors (VAV1,
VAV3, TIAM1 and TIAM2, for which splice variants are known),
which play a critical role in translating extracellular signals into
cytoskeletal dynamics, protein phosphatases (PTPRC (CD45),
PTPN6 (SHP-1) and PPP3CA (calcineurin A)) and adaptors
(DOK2, DOK5, Shc; all AS). In addition to TCR signaling, T cell
adhesion appears to be affected at multiple levels as seen through
alteration at the level of receptors (ITGAL (LFA-1), ITGA4 (VLA-
4), ITGAM (integrin alphaM), ITGB2 (MAC-1)) and GEFs, which
regulate their coupling to the cytoskeleton.
RG and AS gene representation in public databases
Assuming that at least some RG/AS genes being regulated in
response to PI3K disruption might represent gene products
already linked to T cell suppression, we explored microarray,
EST and alternative splicing data in public databases for
comparative analysis. From these gene lists, we specifically
identified genes showing different transcripts under normal versus
T cell suppression conditions (Table S1). In this list ATM, PRMT5
and VCL (vinculin) overlapped with the RG list from the exon
array and CALD1, LCK and MXI1 overlapped with our AS gene
list, thus providing additional evidence for these genes having
different products under different conditions. ATM was found to
promote T cell survival on interaction with HTLV-I p30 (KEGG
pathway hsa05166) [46]. Vinculin (VCL) and caldesmon 1 (CALD1)
have established roles in actin cytoskeleton regulation and
stabilization during focal adhesion, migration, invasion and
proliferation, although this was not yet confirmed to apply to T
cells. [47][48]. Interestingly, the non-muscle isoform of CALD1 is
produced from an AS transcript [49]. An MXI1 isoform generated
on AS has been reported earlier to antagonize Myc functions and
has thus been suggested to serve as a suppressor of solid tumors
[50], and there is evidence it may act as a T cell quiescence factor
too [51]. Most interestingly, neuropilin-1 (encoded by the AS
NRP1) has been directly implicated in regulating T cell activation
at the level of the immune synapse (IS) by us and others previously
[52],[53].
The KEGG pathway analysis showed a higher number of AS
genes than expected to be involved in cancer pathways (hsa05200).
The AS and RG lists were checked against the Tumor Gene
Family of Databases (http://www.tumor-gene.org/TGDB/tgdb.
html) and several genes overlapped, including mitogen activated
protein kinases and cyclin-dependent kinases from the AS list.
Discussion
There has been increasing interest in studying T cell transcrip-
tion and alterations of it at a whole genome level and this, in
common with our study, has included the Exon ST array, and
deep sequencing [54][34,55]. The contribution of these studies to
identifying key elements in T cell activation has been extremely
important, yet the approach taken previously differs from our
setting in that we did not evaluate stimulation dependent
parameters, but rather concentrated on genes regulated down-
stream of PI3K to get a handle on their impact on T cell
suppression. Also applicable to these studies, much work has been
done on the implementation, validation and improvement of
algorithms for the detection of alternative splicing. Since most
algorithms, after visual inspection of probeset intensity distribu-
tion, turned out to be unsatisfactory and revealed quite a large
number of false positive genes that were either regulated or not
changed at all, we decided to use a more stringent algorithm
instead. A higher stringency appears to be justified, because,
although there is good comparability between 39IVT arrays and
exon arrays regarding selectivity and sensitivity levels on gene level
[56], around a 2.2 times higher variation in exon arrays compared
to 39IVT arrays was also described [57]. This is in line with the
observation in our laboratory, where quality assessment of
Affymetrix ST arrays compared to 39IVT arrays showed that
ST arrays had more outliers and lower reproducibility. This may
be due to a more challenging selection of optimal probesets due to
closer spacing [32]. The use of random primers, which is necessary
to avoid a 39 bias of the transcripts, may also add some variation.
Further, using core probesets only, resulted in a significant
reduction of the probesets per exon so that an exon was only
represented by one probeset. However, like in another study [57]
in our dataset more than 80% of the probe level intensities for full
and extended probesets were around the background level (data
not shown). Thus, even though it is possible that only one
probeset/exon out of a larger number of probesets is excised, we
decided to focus on, longer regions showing comparable regulation
as well as distinct peaks by a sliding window, where the average
value of three consecutive probesets was taken as signal intensity
and single peaks in either direction were leveled. This reduced the
number of AS genes to approximately one third. Using gene signal
intensities derived from the Affymetrix Expression Console
software for the detection of regulated but not spliced genes
resulted in a high number of false positive genes that were spliced.
In particular, for genes having extremely high logFC values within
the spliced part, averaged signal intensities tended to show large
changes. We tried to avoid this problem by using the probeset
Figure 3. Affected pathways based on SI genes (A) or genes commonly up-regulated or down-regulated (B). Red bars show the number of observed
genes in the dataset, blue bars show the statistically expected number of genes, given the result to be random.
doi:10.1371/journal.pone.0050695.g003
Table 2. TNFSF/TNFR-SF related genes affected on PI3K
disruption in T cells.
Gene symbol alternative name list
variant
known
TNFSF8 CD30L, RG yes
TNFSF11 RANKL, TRANCE, CD254 AS no
TNFSF12 APO3L, TWEAK, AS yes
TNFSF13 APRIL, CD256 AS yes
TNFSF15 VEGI, TL1 AS yes
TNFSF18 GITRL AS no
C1QTNF5 LORD, C1Q and TNF related 5 AS no
C1QTNF6 CTRP6 AS yes
C1QTNF7 CTRP7 AS yes
TNFRSF8 CD30, Ki-1 AS yes
TNFRSF10D TRAIL-R4, CD264 RG no
TNFRSF21 DR6, CD358 AS no
TNFRSF25 DR3, APO-3, TRAMP AS yes
FAIM3 FcR for IgM, TOSO RG yes
TNFAIP8L2 TNF-a-induced protein 8-like2 AS no
doi:10.1371/journal.pone.0050695.t002
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intensities and the selection of genes having only little variation of
their probeset logFCs. Requiring 90% of all probesets to be
differentially expressed in all samples helped to evade this problem
and significantly increased the correct classification rate.
Functional analysis of the AS and RG genes showed some
unique features, but also significant overlaps in the pathways and
GO terms. In both cases, cell cycle appeared to be significantly
overrepresented. For a particular family of proteins, the phospha-
tidylinositol-3,4,5-trisphosphate 5-phosphatase or SHIP family,
some members were shown to be RG (INPP4B and INPP5D),
while others were AS (INPPL1, INPP5B and INPP5F). Splice
variants of INPP5D (also referred to as SHIP-1) are also known,
and based on inclusion of intron-derived sequences, us and others
have suggested an alternatively spliced pre-mRNA as a source for
translation of SIP110 [58][21]. As only revealed for the murine
Ship1 thus far, the intron preceding exon 6 also harbors a
transcriptional start site [59,60], and therefore SIP110 may also be
produced from a separate transcript which would not appear as
AS in our human assay. PI3K dependent regulation of SHIP
family members at different levels suggests that a combination of
differential expression and alternative splicing are used to regulate
T cell suppression or modulate pathways related to this process as
reported earlier [55]. Targeting of lipid metabolism which plays a
key role in TCR signaling may serve as an example as revealed in
Figure 4. T cell receptor signaling pathway. Green indicates a down-regulated gene, red indicates an up-regulated gene. Spliced genes are
marked in grey.
doi:10.1371/journal.pone.0050695.g004
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our study. In addition to the INPP genes referred to above,
important components in sphingolipid turnover such as CHPT1,
GALC and SPHK1 or ACER3 were also subject to AS or RG,
respectively. Interestingly, shRNA mediated ablation of ACER3,
which hydrolyzes unsaturated long chain ceramides and was
classified as down-regulated, was previously linked to inhibition of
proliferation of non-lymphoid cells [61].
In general, genes appearing as RG on PI3K disruption would
be expected to include those whose expression is regulated through
PI3/AktK activation. This pathway takes part in NF-kB and
STAT activation, yet also in release of transcriptional repressors
that are inactivated on PI3K/Akt activation, such as FOXOs [16].
Though nuclear exclusion and therefore functional inhibition of
FOXO1 is strongly dependent on PI3K driven Akt activation,
only a very limited number of previously identified FOXO1
targets appeared to be affected in our analysis. Though p21INK4a
and sestrin 3 proved to be regulated, typical targets such as FASL,
CDKN1B (p27Kip) or TNFSF10 (TRAIL) [45],[44] were not and
this may be due to the fact that they did not reach the statistical
threshold in our analysis, largely because of variation in signal
intensities between samples. FOXO targets were, however, also
found in the AS list corroborating the complementarity of
mechanisms affecting particular pathways in potentially mediating
T cell suppression [34,55]. In contrast to these previous studies,
which measured stimulation dependent transcriptional alterations
in Exon arrays of T cells (this did not include the inhibition
approach we took), one study addressed differential accumulation
of transcripts in T cells upon PI3K inhibition by a conventional
micro-array analysis [29]. Some candidates identified in this study
also appeared as RGs in ours (IL-2B and CTLA-4 as up-, and IL-3
as down-regulated) while others – such as FoxP3 – did not appear
in our lists. Most likely, substantial differences in cell material and
stimulation protocols (they used naive CD4+ T cells and
CD4+CD82 thymocytes as opposed to total CD3+ cells and
harvested RNAs after a total stimulation period of 42 hrs rather
than 24 hrs) may account to a major extent for discrepancies seen.
Availability and functions of splice regulatory factors are the
most obvious targets in AS regulated downstream of PI3K
activation (and ablation thereof). A few have been identified as
PI3K effectors [20,28][21],[22],[62], yet their actual targets in
regulating exonic inclusion/skipping mainly have not. It is thus
unpredictable which PI3K effectors specifically account for AS
from genes detected by the array and is there no algorithm
allowing for a systematic search for exons affected (those shown in
Figure 1 were manually determined based on published data).
This is especially complicated by the fact that for many genes
listed, exon usage and splice variants are not described, or if these
are available, conflicting information is provided on enquiry of the
NCBI or Affymetrix platforms. Thus, algorithms correcting for
these inconsistencies and allowing for alignment of exonic
inclusion/skipping as detected by the array need to be developed
for optimal processing of information given. With regard to
functional terms, it is, however, noteworthy that in addition to
targeting genes directly involved in cell cycle progression (as also
seen for RGs), AS appeared to preferentially affect genes involved
in cytoskeletal dependent processes such as motility, invasion and
chemotaxis, especially at the membrane proximal level (Figure S2).
On analysis of combined RG/AS candidates, it appeared that
certain gene families and pathways were particularly subject to
PI3K dependent regulation (Table 2), including the TNF/TNF-R
and BCL superfamilies, or lipid metabolism, which has been
referred to above. Genes involved in cancer progression were also
readily identified (as outlined for ATM and MXI above), and these
also included WRAP53 as AS. Its gene product, WRAP53
(telomerase Cajal body protein, TCAB1) specifically interacts
with TERT (AS on PI3K ablation) and essentially regulates
telomerase trafficking, Cajal body formation and telomerase
function and is thus of key importance for survival of particularly
tumor cells [63],[64]. Interestingly, WRAP53 transcripts serve as
natural anti-sense RNAs of p53 which regulate endogenous p53
mRNA and protein levels thereby supporting cellular apoptosis
[38,65]. Which of these WRAP53 functions applies to the
regulation of T cell activation or survival is as yet unknown and
needs detailed functional assessment. In addition to these proteins
directly involved in cell division and survival, gene families
regulating cytoskeletal dynamics also appear to be substantially
affected (as exemplified for VCL, CHN1 and CALD1 above), which
may be particularly important in regulating T cell functions in
addition to those highlighted in Figure 4. The role of CD3c within
the TCR complex is virtually unknown, yet interestingly, this
component as well as LCK has been found down-regulated in a
microarray based study late after T cell activation [66]. Formal
proof of the respective activity of especially the AS candidates in
abrogating T cell responsiveness alone or in combination will have
to be provided through recombinant expression and subsequent
functional analysis as performed by us earlier for SIP110 [21].
Supporting Information
Figure S1 RNAs isolated from T cell enriched periph-
eral blood lymphocytes PMI/iono activated (S) or not
(U) for the time intervals indicated were used as
templates for RT-PCR detection of transcripts including
exon 8 (lanes 2, 4, and 6).
(EPS)
Figure S2 Enriched functional categories in SI. Signif-
icantly enriched categories marked in red. The analysis
was performed using the Gene Set Analysis Toolkit V2 (http://
bioinfo.vanderbilt.edu/webgestalt/).
(TIF)
Figure S3 Enriched functional categories in down-
regulated genes. Significantly enriched categories
marked in red. The analysis was performed using the Gene
Set Analysis Toolkit V2 (http://bioinfo.vanderbilt.edu/
webgestalt/).
(TIF)
Figure S4 Enriched functional categories in up-regulat-
ed genes. Significantly enriched categories marked in red. The
analysis was performed using the Gene Set Analysis Toolkit V2
(http://bioinfo.vanderbilt.edu/webgestalt/).
(TIF)
Table S1 Some of the genes from public databases
showing alternative transcripts under normal versus T
cell suppression conditions.
(XLSX)
Table S2 Primers used to amplify RG and AS tran-
scripts (and variable (V) and constant (R) regions
therein.
(XLSX)
Table S3 Genes found to be alternatively spliced.
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Table S4 Genes found to be regulated.
(XLSX)
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leukocyte transendothelial migration.
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